Stay updated on Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page.

Latest updates to the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page
- Check7 days agoChange DetectedA new revision, v3.3.4, was added to the record history and the previous revision v3.3.3 was removed.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check36 days agoChange DetectedNew and updated major study data sections have been added, including Adverse Events, Outcome Measures (Results), Baseline Characteristics, and Participant Flow. The latest version shows Returned: 2025-12-09 and QC review not concluded.SummaryDifference0.7%

- Check50 days agoChange DetectedRecord History now includes the 'Results Submitted' status and removes the 'No Results Posted' option from the changes list; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page now shows Revision: v3.3.2 and removes Revision: v3.2.0 as part of a UI version update. This change does not affect the study record content.SummaryDifference0.0%

- Check64 days agoChange DetectedRemoved the page-wide notice about government funding delays and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page.